A Phase 2b, Randomised, Double-blind, Placebo-controlled, Parallel-arm, Multicenter Study Evaluating the Safety and Efficacy of Tesnatilimab in Patients with Moderately to Severely Active Crohn’s DiseaseMatthieu Allez, Taku Kobayashi, Brian G. Feagan et al.|Journal of Crohn s and Colitis|2023Cited by 11
BMP-driven NRF2 activation in esophageal basal cell differentiation and eosinophilic esophagitisMei‐Lun Wang, Jeffrey H. Peters|UNC Libraries|2020Cited by 1